COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience

The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), identified in late 2019 as the causative agent of COVID-19, was declared a pandemic by the World Health Organization on 11 March 2020. Widespread community transmission in the United States triggered a nationwide shu...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, Katie, Saucier, Anna, Kim, Haesook T., Acharya, Utkarsh, Mo, Clifton C., Porter, Julie, Albert, Cindy, Cutler, Corey, Antin, Joseph H., Koreth, John, Gooptu, Mahasweta, Romee, Rizwan, Wu, Catherine J., Soiffer, Robert J., Nikiforow, Sarah, Jacobson, Caron, Ho, Vincent T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869610/
https://www.ncbi.nlm.nih.gov/pubmed/33560397
http://dx.doi.org/10.1182/bloodadvances.2020003883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869610/
https://www.ncbi.nlm.nih.gov/pubmed/33560397
http://dx.doi.org/10.1182/bloodadvances.2020003883

Ejemplares similares